When was tekturna launched

Search tips. Novartis hopes of blockbuster status for Rasilez dashed Promotion of aliskiren products in combination with an ACE inhibitor or ARB to cease after adverse events cause trial in high risk patients to end 21st December Share Print Friendly. American journal of hypertension : journal of the American Society of Hypertension Jan;20 1 American journal of hypertension : journal of the American Society of Hypertension Jan;25 1 International journal of clinical practice Nov;60 11 Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.

Hypertension Sep;46 3 Epub Aug Circulation Mar 1; 8 Epub Feb Stanton A Therapeutic potential of renin inhibitors in the management of cardiovascular disorders. American journal of cardiovascular drugs : drugs, devices, and other interventions ;3 6 For additional information regarding Tekturna or hypertension, please visit the Tekturna web page.

Lundbeck Takeda Pharmaceuticals U. Tekturna aliskiren Profile. Profile Contact Information. Currently Enrolling Trials Show More.

General Information Tekturna is an orally active, nonpeptide, potent renin inhibitor. Clinical Results FDA Approval FDA approval of Tekturna was based on the results of six clinical trials of aliskiren monotherapy, one trial of aliskiren alone and in combination with hydrochlorothiazide and one trial of aliskiren alone and in combination with valsartan.

Ongoing Study Commitments Novartis has agreed to a deferred pediatric study under PREA for the treatment of hypertension in pediatric patients ages 6 to 16 years.

Tekturna, which is sold under the brand name Rasilez in the U. The drug is now sold by Novartis, which pays royalties to Speedel. Separately, in an interview with the Financial Times, Novartis chief executive Daniel Vasella said that Tekturna, which was launched last year, has performed as expected. But Vasella noted that the company's current best-seller, Diovan, had also started slowly.

It never took of like a rocket. How about being grateful for modified food starch, monosodium glutamate, butylated hydroxyanisol and butylated hydroxytoluene? Novartis launches two new big trials on Tekturna Published: June 17, at a.